Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL)


Por: Maschmeyer, G, De Greef, J, Mellinghoff, SC, Nosari, A, Thiebaut-Bertrand, A, Bergeron, A, Franquet, T, Blijlevens, NMA, Maertens, JA, ECIL

Publicada: 1 abr 2019
Resumen:
A multitude of new agents for the treatment of hematologic malignancies has been introduced over the past decade. Hematologists, infectious disease specialists, stem cell transplant experts, pulmonologists and radiologists have met within the framework of the European Conference on Infections in Leukemia (ECIL) to provide a critical state-of-the-art on infectious complications associated with immunotherapeutic and molecular targeted agents used in clinical routine. For brentuximab vedotin, blinatumomab, CTLA4- and PD-1/PD-L1-inhibitors as well as for ibrutinib, idelalisib, HDAC inhibitors, mTOR inhibitors, ruxolitinib, and venetoclax, a detailed review of data available until August 2018 has been conducted, and specific recommendations for prophylaxis, diagnostic and differential diagnostic procedures as well as for clinical management have been developed.

Filiaciones:
Maschmeyer, G:
 Klinikum Ernst von Bergmann, Dept Hematol Oncol & Palliat Care, Charlottenstr 72, D-14467 Potsdam, Germany

De Greef, J:
 Catholic Univ Louvain, St Luc Univ Hosp, Dept Internal Med & Infect Dis, Brussels, Belgium

 Henri Mondor Teaching Hosp, AP HP, Dept Hematol, Creteil, France

Mellinghoff, SC:
 Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany

 Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany

Nosari, A:
 ASST Grande Osped Metropolitano Niguarda, Dept Hematol, Milan, Italy

Thiebaut-Bertrand, A:
 Univ Grenoble Alpes, Dept Hematol, Grenoble, France

Bergeron, A:
 Univ Paris Diderot, St Louis Hosp, AP HP, Dept Pneumol, Paris, France

Franquet, T:
 Hosp Santa Creu & Sant Pau, Dept Radiol, Barcelona, Spain

Blijlevens, NMA:
 Radboud Univ Nijmegen, Med Ctr, Dept Hematol, Nijmegen, Netherlands

Maertens, JA:
 Univ Hosp Leuven, Dept Hematol, Leuven, Belgium

 Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium
ISSN: 08876924





LEUKEMIA
Editorial
SPRINGERNATURE, CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND, Reino Unido
Tipo de documento: Review
Volumen: 33 Número: 4
Páginas: 844-862
WOS Id: 000463162400003
ID de PubMed: 30700842
imagen Green Published, Hybrid Gold

MÉTRICAS